✦ LIBER ✦

Adjuvant extension of chemotherapy after neoadjuvant therapy may not improve outcome in early-stage breast cancer

✍ Scribed by M. Knauer; A. Haid; Y. Schneider; R. Köberle-Wührer; A. Lang; T. Winder; R. Alton; Z. Jasarevic; C. Säly; F.A. Offner; E. Wenzl; A. deVries

Book ID: 116443443
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 254 KB
Volume: 35
Category: Article
ISSN: 0748-7983
DOI: 10.1016/j.ejso.2008.10.001

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Advances in the Treatment of Early-Stage

Advances in the Treatment of Early-Stage Breast Cancer: Integrating Chemotherapy as Adjuvant Therapy

✍ G. Kesava Reddy; Joyce A. O'Shaughnessy 📂 Article 📅 2005 🏛 CIG Media Group, LP. 🌐 English ⚖ 89 KB

Racial differences in acute toxicities o

Racial differences in acute toxicities of neoadjuvant or adjuvant chemotherapy in patients with early-stage breast cancer

✍ Hyo Sook Han; Isildinha M. Reis; Wei Zhao; Katsumasa Kuroi; Masakazu Toi; Eiji S 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 272 KB

Selection of local therapy after neoadju

Selection of local therapy after neoadjuvant chemotherapy in patients with stage IIIA,B breast cancer

✍ David N. Danforth; JoAnne Zujewski; Joyce O'Shaughnessy; David Riseberg; Seth M. 📂 Article 📅 1998 🏛 Springer 🌐 English ⚖ 833 KB

Biweekly docetaxel and gemcitabine as ne

Biweekly docetaxel and gemcitabine as neoadjuvant chemotherapy followed by adjuvant doxorubicin and cyclophosphamide therapy in stage II and III breast cancer patients: results of a phase II study

✍ L. G. Estévez; P. Sánchez-Rovira; M. Dómine; A. León; I. Calvo; A. Jaén; V. Casa 📂 Article 📅 2007 🏛 Springer Milan 🌐 Spanish ⚖ 80 KB

Cost-effectiveness of exemestane versus

Cost-effectiveness of exemestane versus tamoxifen as adjuvant therapy for early-stage breast cancer after 2–3 years treatment with tamoxifen in Sweden

✍ J. Lundkvist; Wilking; S. Holmberg; M. Lidgren; L. Jönsson 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 123 KB

The risk of amenorrhoea after adjuvant c

The risk of amenorrhoea after adjuvant chemotherapy for early stage breast cancer is related to inter-individual variations in chemotherapy-induced leukocyte nadir in young patients: Data from the randomised SBG 2000-1 study

✍ Mikkel Rosendahl; Johan Ahlgren; Jørn Andersen; Jonas Bergh; Carl Blomquist; Eli 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 170 KB